November 21st 2024
The CDMO's California facility welcomes new production suites, a revamp of its development labs, and more.
November 19th 2024
The CDMO is investing $3.6 million toward boosting its advanced labeling, automated visual inspection, and fill-finish tech.
November 8th 2024
One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.
October 28th 2024
With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.
October 8th 2024
With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.
Thermo Fisher, UCSF collaborate on future cell therapy manufacturing center
Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services
Novasep enhances HPAPI manufacturing know-how
Expansion establishes role it plays in the oncology sector, company suggests
Study: Mislabeling costs $1.31M annually from production line shutdowns
Pauses per manufacturer due to label-printing problems occur just under six times a year, on average, report finds
Aenova bolsters fill-and-finish capabilities
New sterile production area at Italy facility aims to benefit biologics manufacturing, such as BSL vaccines
BioNTech establishes regional hub in Singapore
Company also plans to design a manufacturing site for future mRNA vaccines and therapeutics
Catalent acquires Promethera subsidiary to further pDNA manufacturing
Will use new facility in Belgium for commercial production of plasmid DNA
Lonza steps up production arsenal, to upgrade capacity in US and Europe
CDMO giant invests nearly $1 billion in Switzerland and New Hampshire sites
Moderna revamps its manufacturing tech center
Renovation more than doubles size of Massachusetts facility
Moderna to rev up vaccine supply to up to 3 billion doses by 2022
Company also says that drug substance manufacturing can double at its facilities
Gilead to assist Indian manufacturers with remdesivir production
As India Covid cases continue to spike, biotech company will provide resources to help boost local manufacturing
AavantiBio, Catalent team up on AAV manufacturing for rare genetic diseases
Partnership will begin with tackling Friedreich’s ataxia, then extend to other gene transfer therapies
Sanofi will help produce Moderna’s Covid vaccine
Intends to provide fill-and-finish services for up to 200 million doses
BMS to construct cell therapy manufacturing facility in the Netherlands
Leiden site will be the company's fifth such facility, and first in Europe
Report: Emergent pauses J&J vaccine production at Baltimore plant
FDA launches investigation into last month’s dose contamination
Abzena unveils location for its latest biologics GMP site
Sanford, NC, facility will be its sixth globally
Catalent undergoes facility expansion, more than doubling its capacity
Madison, WI, site now contains five manufacturing suites
Sanofi invests $476 million in Singapore vaccine production site
Upon completion of five-year project, the location will serve as Asian hub for dose manufacturing
Catalent and Moderna expand their manufacturing collaboration
Dedicate new high-speed vial filling line for production of Moderna's Covid-19 vaccine
Ajinomoto expands its manufacturing arrangement with AstraZeneca
Agreement will now include fill-finish services at San Diego facility
China's Sinovac reveals capacity ramp-up for its Covid-19 vaccine
With construction of third production line finished, biotech company says it can manufacture two billion doses annually
KD Pharma obtains Rohner AG’s manufacturing assets
Acquisition further develops KD Pharma’s CDMO capabilities
GSK to support Novavax Covid-19 vaccine production effort
The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate
Pelican BioThermal bolsters its dry ice shipper options
Expansion in response to growing industry demand for products to transport temperature-sensitive cell and gene therapies
Pfizer to stop manufacturing biosimilars in China
Location will be purchased by WuXi Biologics, according to report
SCHOTT delivers vials equating to 1 billion Covid vaccine doses
Puts packaging business on pace for 2 billion by end of year
Arranta Bio breaks ground on Massachusetts microbiome facility
The 130,000-square-foot site will be the CDMO's third location
Novartis and CureVac collaborate on vaccine manufacturing
Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV
Merck signs BARDA manufacturing agreement
In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production
Report: Merck to help make J&J's Covid-19 vaccine
Rivals will team up in order to accelerate supply
AMRI becomes approved manufacturer of lipid excipients for Pfizer-BioNTech vaccine
Joins network of manufacturers contributing efforts to increase supply